 | Up a level |
Seibold, F; Münger, C (2012). Durchblutungsstörungen im Abdomen. Informierte Arzt, pp. 45-47. Erlenbach (CH): Aerzteverlag medinfo AG
Rogler, G; Beglinger, C; Mottet, C; Seibold, F; Gross, V (2011). [Topical therapy of ulcerative colitis]. Praxis - schweizerische Rundschau für Medizin, 100(23), pp. 1413-24. Bern: Huber 10.1024/1661-8157/a000722
Seibold, F (2011). Eisenmangel: Ein häufiges Problem bei Patienten mit chronisch entzündlichen Darmerkrankungen. SMCCV Info, 73(9) Aarau: Schweizerische Morbus Crohn / Colitis ulcerosa Vereinigung SMCCV
Pittet, V; Juillerat, P; Michetti, P; Vader, J-P; Burnand, B; Rogler, G; Beglinger, C; Seibold, F; Mottet, C; Felley, C; Gonvers, J-J; Froehlich, F; Swiss IBD Cohort Study Group, The (2010). Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort. Alimentary pharmacology & therapeutics, 32(8), pp. 1007-16. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2010.04434.x
Dignass, AU; Eriksson, A; Kilander, A; Pukitis, A; Rhodes, JM; Varicka, S; Collaborators Lochs, H; Porst, H; von Boyen, G; Seibold, F; Emmrich, J (2010). Clinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. Alimentary pharmacology & therapeutics, 12(Jun;31), pp. 1286-95. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2010.04295.x
Banerjee, S; Oneda, B; Yap, L M; Jewell, D P; Matters, G L; Fitzpatrick, L R; Seibold, F; Sterchi, E E; Ahmad, T; Lottaz, D; Bond, J S (2009). MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal immunology, 2(3), pp. 220-31. New York, N.Y.: Nature Publishing Group 10.1038/mi.2009.3
Seibold, F; Gschossmann, J (2009). Pathophysiologische Betrachtungen zu Unterschieden und Gemeinsamkeiten. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin Neuhausen (CH): Rosenfluh
Schoepfer, AM; Beglinger, C; Straumann, A; Trummler, M; Renzulli, P; Seibold, F (2009). Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflammatory bowel diseases, 15(12), pp. 1851-1858. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20986
Gschossmann, J; Seibold, F (2009). IBS und IBD: aktuelle Therapie. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin, 1, pp. 29-31. Neuhausen (CH): Rosenfluh
Schoepfer, A; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2008). Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflammatory bowel diseases, 14(1), pp. 32-39. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20275
Schoepfer, A M; Schaffer, T; Seibold-Schmid, B; Müller, S; Seibold, F (2008). Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterology and motility, 20(10), pp. 1110-8. Oxford: Blackwell Science 10.1111/j.1365-2982.2008.01166.x
Schoepfer, A M; Gschossmann, J; Scheurer, U; Seibold, F; Straumann, A (2008). Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy, 40(2), pp. 161-4. Stuttgart: Thieme 10.1055/s-2007-995345
Beglinger, C; Binek, J; Braegger, C; Michetti, P; Rogler, G; Sauter, B; Seibold, F; Straumann, A (2008). Infliximab Monotherapie versus Kombinationstherapie mit Immunmodulatoren. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(1), pp. 32-33. Neuhausen (CH): Rosenfluh
Seibold, F (2008). Editorial zur Antikörpertherapie bei IBD. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(1), p. 3. Neuhausen (CH): Rosenfluh
Seibold, F (2008). What is the optimal maintenance treatment for Crohn's disease. Inflammatory bowel diseases, 14(Suppl. 2), S255-S256. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20672
Schoepfer, AM; Trummler, M; Seeholzer, P; Criblez, D; Seibold, F (2007). Accuracy of Four Fecal Assays in the Diagnosis of Colitis. Diseases of the colon & rectum, 50(10), pp. 1697-1706. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1007/s10350-007-0303-9
Schaffer, T; Mueller, S; Flogerzi, B; Seibold-Schmid, B; Schoepfer, A; Seibold, F (2007). Anti-Saccharomyces cerevisiae antibodies in Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflammatory bowel diseases, 13(11), pp. 1339-1346. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20228
Seibold, F; Boldt, AB; Seibold-Schmid, B; Schoepfer, AM; Flogerzi, B; Mueller, S; Kun, JF (2007). Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: A family study. Inflammatory bowel diseases, 13(9), pp. 1077-1082. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20156
Seibold, F; Boldt, AB; Seibold-Schmid, B; Schoepfer, AM; Flogerzi, B; Mueller, S; Kun, JF (2007). Deficiency for mannan-binding lectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their relatives. Gut, 56(1), p. 152. London: BMJ Publishing Group 10.1136/gut.2006.110007
Schaffer, T; Mueller, S; Schoepfer, AM; Hilty, A; Bodmer, T; Seibold, F (2007). Association of anti-mycobacterial IgG with antibodies against the yeast Saccharomyces cerevisiae in patients with Crohns's disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl 38), 8S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Gschossmann, J; Scheurer, U; Seibold, F; Straumann, A (2007). Esophageal strictures in Eosinophilic Esophagitis: Dilation is an Effective and Safe Therapeutic Alternative after Failure of Topical Corticosteroids. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 6S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Flogerzi, B; Fallegger, S; Schaffer, T; Mueller, S; Nicod, L; Seibold, F (2007). Use of Interferon-gamma Release Assay for the Diagnosis of Latent Infection with Mycobacterium Tuberculosis in Inflammatory Bowel Disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 5S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2007). Discriminating IBD from IBS: a Comparative Evaluation of the Test Performance of Fecal Markers and IBD Antibodies. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 5S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2007). Elevated antibodies against Flagellin support the concept of low-grade Mucosal Inflammation in Irritable Bowel Syndrome. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 4S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2007). Elevated Antibodies against Flagellin support the Concept of Low Grade Mucosal Inflammation in Irritable Bowel Syndrome. Gastroenterology Philadelphia, Pa.: Elsevier
Schoepfer, AM; Mueller, S; Criblez, D; Schaffer, T; Seibold, F (2007). Circulating Levels of Leptin, Adiponectin and Alpha-MSH in Crohn's Disease Patients differ from a Matched Population. Journal of Crohn's & Colitis(1), AO03. Amsterdam: Elsevier
Schoepfer, AM; Gschossmann, J; Seibold, F; Scheurer, U; Straumann, A (2007). Esophageal Strictures in Eosinophilic Esophagitis: Dilation is an effective and safe Alternative after Failure of topical Corticosteroids. Journal of Crohn's & Colitis(1), AP14. Amsterdam: Elsevier
Schoepfer, AM; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2007). Biomarkers for Discrimination of IBD versus IBS: Accuracy of Fecal Leucocyte Markers is improved when combined with IBD Antibody Panels. Journal of Crohn's & Colitis(1), AP13. Amsterdam: Elsevier
Brunner, B; Scheurer, U; Seibold, F (2007). Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitis. Diseases of the colon & rectum, 50(1), pp. 83-88. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1007/s10350-006-0749-1
Schüpbach, W; Vadday, K; Schaller, A; Brekenfeld, C; Kappeler, L; Benoist, JF; Xuan-Huong, C; Burgunder, J; Seibold, F; Gallati, S; Mattle, H (2007). Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features. Journal of neurology, 254(2), pp. 146-53. Heidelberg: Steinkopff-Verlag; www.steinkopff.springer.de 10.1007/s00415-006-0255-3
Konrad, A; Lehrke, M; Schachinger, V; Seibold, F; Stark, R; Ochsenkühn, T; Parhofer, K; Göke, B; Broedl, U (2007). Resistin is an inflammatory marker of inflammatory bowel disease in humans. European journal of gastroenterology & hepatology, 19(12), pp. 1070-1074. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MEG.0b013e3282f16251
Lehrke, M; Konrad, A; Schachinger, V; Tillack, C; Seibold, F; Stark, R; Parhofer, KG; Broedl, UC (2007). CXCL 16 is a surrogate marker of inflammatory bowel disease. Scandinavian journal of gastroenterology, 43(3), pp. 283-288. London: Informa Healthcare 10.1080/00365520701679249
Beglinger, C; Dudler, J; Mottet, C; Nicod, L; Seibold, F; Villiger, P; Zellweger, J (2007). Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss medical weekly(137), 620-2 A. Muttenz: EMH Schweizerischer Ärzteverlag
Seibold, F (2007). Therapie gastroenterologischer Infektionen. Medical journal TMJ, p. 1. Neuhausen (CH): Rosenfluh
Seibold, F (2007). Irritable Bowel Syndrome. Volkserkrankung IBS ist ein Reizthema. Hausarztpraxis - Fortschritte der Medizin(Special), pp. 9-12. Zürich: Prime Public Media AG
Seibold, F; Schöpfer, A (2007). Therapie der Colitis ulcerosa. Ars medici - Schweizer Zeitschrift für Hausarztmedizin(VI), pp. 1-2. Neuhausen (CH): Rosenfluh
Seibold, F (2007). Volkserkrankung IBS ist ein Reizthema. Hausarztpraxis - Fortschritte der Medizin(Special), pp. 9-12. Zürich: Prime Public Media AG
Bauerfeind, P; Beglinger, C; Beltinger, J; Braegger, C; Eigenmann, F; Fried, M; Guyot, J; Hürlimann, R; Michetti, P; Seibold, F; Straumann, A (2006). Infliximab - Recommendations practiques pour le traitment de la maladie de Crohn. Revue médicale suisse, 2(74), pp. 1807-15. Genève: Médecine & Hygiène
Broedl, UC; Schachinger, V; Lingenhel, A; Lehrke, M; Stark, R; Seibold, F; Goke, B; Kronenberg, F; Parhofer, KG; Konrad-Zerna, A (2006). Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflammatory bowel diseases, 13(4), pp. 391-397. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20078
Schoepfer, A; Seibold, F (2006). Kolorektales Karzinom: Screening und Diagnostik. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(1), pp. 18-9. Neuhausen (CH): Rosenfluh
Schoepfer, AM; Seibold, F (2006). Aktuelle Therapie der Colitis ulcerosa. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(3), pp. 10-11. Neuhausen (CH): Rosenfluh
Schöpfer, A; Bielecki, J; Seibold, F; Giezendanner, S; Balsiger, B; Greeve, J; Christian, E; Weimann, R; Netzer, P; Scheurer, U; Gschossmann, JM (2006). Zweiwöchige Argon-Plasma-Koagulation als sichere und effektive Behandlungsoption für blutende hyperplastische Riesenpolypen bei einer Patientin mit Wassermelonenmagen und Leberzirrhose. Endoskopie heute(19), p. 52. Stuttgart: Thieme
Mueller, S; Flogerzi, B; Schaffer, T; Fleetwood, A; Schoepfer, A; Seibold, F (2006). Non T-cell derived Galectin-3 is immunoregulatory and is reduced in the inflamed intestinal epithelium in IBD. Gastroenterology, 130/(Suppl 33), A3616/A37. Philadelphia, Pa.: Elsevier
Schaffer, T; Müller, S; Seibold, F (2006). Mechanisms of anti-Saccharomyces cerevisiae antibody development in Crohn's Disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 6:(Suppl 33) Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2006). Antibodies to Flagellin: Clinical significance in Inflammatory bowel disease. American journal of gastroenterology(1101), A1158. New York, N.Y.: Nature
Schoepfer, A; Trummler, M; Seibold, B; Seeholzer, P; Seibold, F (2006). Accuracy of four fecal markers in inflammatory colonic disease. Poster präsentiert am DDW Los Angeles Mai 2006. Gastroenterology(130), A217. Philadelphia, Pa.: Elsevier
Schoepfer, A; Trummler, M; Seibold, B; Seeholzer, P; Seibold, F (2006). Diagnosis of Inflammatory Bowel Disease: which Laboratory Parameter helps the most? Gastroenterology(130), A208. Philadelphia, Pa.: Elsevier
Seibold, F; Schoepfer, A; Kaindl, G (2008). Clinical efficacy of infliximab and its effect on ability to work in a Bern IBD cohort. In: Jahreskongress SGG / SGCV.
